[Rituximab for treatment of Felty's syndrome]. / Rituximab zur Therapie des Felty-Syndroms.
Z Rheumatol
; 73(5): 465-6, 468, 2014 Jun.
Article
in De
| MEDLINE
| ID: mdl-24659095
ABSTRACT
Felty's syndrome is a rare variant of severe seropositive rheumatoid arthritis with neutropenia and splenomegaly. It is difficult to treat and associated with a poor prognosis due to the substantial risk of infections. This article presents the case of a patient with refractory disease who responded to rituximab with permanent normalization of neutrophil counts. Repeated infusions were necessary to induce and maintain remission.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Splenomegaly
/
Felty Syndrome
/
Antibodies, Monoclonal, Murine-Derived
/
Neutropenia
Type of study:
Prognostic_studies
Limits:
Aged
/
Humans
/
Male
Language:
De
Journal:
Z Rheumatol
Year:
2014
Document type:
Article